Production of anti-human cannabinoid receptor 2 (CB2) monoclonal antibody using non-viral vectorinduced human CB2 expressing myeloma as an immunogen
Cannabinoid receptor 2 (CB2) of the cannabinoid system is predominantly expressed on immune cells and involved in a diverse range of immune functions. However, the role of CB2 in immunoregulation is still controversial. One of the challenges in the detailed characterization and functional study of CB2 is the lack of CB2-specific monoclonal antibodies (mAbs).